BPC 157: The peptide with big claims and scant evidence STAT FDA moves toward easing restrictions on certain peptides BioPharma Dive FDA Compliance for Peptide Therapy and BPC 157 Holt Law The science behind the peptide craze Scientific American The peptide problem: Hype is outrunning the evidence The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University